A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tumors

Clinical trial NCT00664586 · TERMINATED

Trial details

NCT number: NCT00664586
Sponsor: Erimos Pharmaceuticals
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Solid Tumors Lymphoma

Start date: 2007-05-01
Primary completion: 2009-04-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.